Freedom Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-54,735
Closed -$135K 929
2020
Q4
$135K Sell
54,735
-14,674
-21% -$35.7K 0.01% 590
2020
Q3
$219K Sell
69,409
-10,181
-13% -$32.5K 0.02% 486
2020
Q2
$232K Sell
79,590
-6,919
-8% -$21.9K 0.03% 475
2020
Q1
$304K Buy
86,509
+651
+0.8% +$2.1K 0.03% 491
2019
Q4
$279K Sell
85,858
-8,017
-9% -$23.3K 0.02% 508
2019
Q3
$203K Sell
93,875
-15,275
-14% -$40.8K 0.02% 636
2019
Q2
$343K Sell
109,150
-12,334
-10% -$40K 0.03% 477
2019
Q1
$452K Buy
121,484
+2,228
+2% +$7.52K 0.04% 403
2018
Q4
$346K Sell
119,256
-8,248
-6% -$22.7K 0.03% 525
2018
Q3
$306K Buy
127,504
+3,302
+3% +$8.1K 0.02% 695
2018
Q2
$291K Sell
124,202
-98,752
-44% -$276K 0.02% 769
2018
Q1
$655K Buy
222,954
+1,268
+0.6% +$3.46K 0.03% 516
2017
Q4
$607K Buy
221,686
+4,109
+2% +$12.6K 0.03% 547
2017
Q3
$738K Sell
217,577
-15,356
-7% -$42.7K 0.04% 451
2017
Q2
$575K Buy
232,933
+1,125
+0.5% +$2.59K 0.03% 511
2017
Q1
$526K Sell
231,808
-30,501
-12% -$67.5K 0.03% 527
2016
Q4
$556K Sell
262,309
-73,455
-22% -$205K 0.03% 447
2016
Q3
$1.13M Sell
335,764
-12,161
-3% -$38.6K 0.07% 212
2016
Q2
$1.09M Buy
347,925
+22,133
+7% +$73.8K 0.07% 201
2016
Q1
$1.08M Buy
325,792
+46,107
+16% +$144K 0.08% 191
2015
Q4
$990K Buy
279,685
+279,158
+52,971% +$1.17M 0.08% 219
2015
Q3
$652K Sell
527
-177,999
-100% -$1.02M 0.07% 254
2015
Q2
$1.15M Buy
178,526
+55,825
+45% +$374K 0.12% 133
2015
Q1
$864K Buy
122,701
+62,752
+105% +$454K 0.1% 170
2014
Q4
$462K Buy
59,949
+35,019
+140% +$277K 0.06% 307
2014
Q3
$186K Buy
+24,930
New +$231K 0.03% 457

Other funds holding PDLI

Freedom Investment Management's PDLI Position: Q1 2021 in Review

Freedom Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 54,735 shares — an estimated $135K sold.

Freedom Investment Management first reported a position in PDLI in Q3 2014 and held it in 26 quarters. The position peaked at $1.15M in Q2 2015. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.

  • Freedom Investment Management reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • Freedom Investment Management sold 54,735 PDL BioPharma, Inc. shares in Q1 2021, an estimated $135K.
  • Freedom Investment Management first reported a position in PDL BioPharma, Inc. in Q3 2014 and held it in 26 quarters.
  • Freedom Investment Management's PDL BioPharma, Inc. position peaked at $1.15M in Q2 2015.
  • 11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.

Based on Freedom Investment Management's 13F filing for Q1 2021, filed 14 May 2021.